VirTra, Inc. Form 10-Q Summary
Business Context and Reporting Period
VirTra, Inc. provides judgmental use-of-force and firearms training simulators, software, content, warranties, installation, training, and subscription services to law enforcement, military, educational, and commercial customers. This unaudited report covers the three months ended March 31, 2024, compared with the three months ended March 31, 2023. VirTra is a smaller reporting company listed on Nasdaq under VTSI.
Financial Performance and Position
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $8.09 million | $10.03 million | Down 19% |
| Gross profit | $5.46 million | $6.95 million | Down 21% |
| Gross margin | 67% | 69% | Down 2 percentage points |
| Operating income | $1.40 million | $3.47 million | Down 60% |
| Net income | $1.22 million | $2.95 million | Down 59% |
| Basic and diluted EPS | $0.11 | $0.27 | Down $0.16 |
| Adjusted EBITDA | $1.91 million | $3.99 million | Down 52% |
| Operating cash flow | $5.14 million | $0.98 million | Up $4.16 million |
Revenue mix shifted toward government customers, which represented 83% of Q1 2024 revenue versus 63% in Q1 2023. International revenue declined to 16% from 32%, while commercial revenue declined to 1% from 5%. STEP revenue increased to $963,864, or 12% of revenue, from $737,515, or 7%.
Cash and cash equivalents were $22.42 million at March 31, 2024, up from $18.85 million at December 31, 2023. Working capital was $33.18 million, broadly consistent with $33.24 million at year-end. Current assets were $47.52 million versus current liabilities of $14.34 million.
Total debt consisted primarily of a secured mortgage note with $7.98 million outstanding, including current and long-term portions. The note bears fixed interest at 3% and matures in August 2031, with a scheduled balloon payment of approximately $5.96 million. Total liabilities were $25.39 million and stockholders’ equity was $43.99 million at March 31, 2024.
Operating cash flow benefited substantially from a $5.18 million reduction in accounts receivable. Capital expenditures were $1.55 million, primarily for property and equipment, and financing activities used $24,402. Ending cash increased by $3.57 million during the quarter.
Material Changes Versus the Prior Comparable Period
- Revenue declined $1.93 million because lower bookings in the fourth quarter of 2023 and first quarter of 2024 were affected by the federal funding continuing resolution and contracts being placed on hold.
- Gross margin declined from 69% to 67%, primarily because costs associated with the second milestone of the Microsoft Prototype contract were recorded in the quarter.
- Operating expenses increased 17% to $4.06 million. Management cited higher payroll and benefits, increased information technology spending for regulatory compliance, and greater travel expenses to expand sales territories.
- Other income increased to $329,271 from $116,413, primarily because of lease payments from a subtenant at the former facility.
- Property and equipment increased to $16.80 million from $15.49 million, reflecting substantial capital expenditures.
- Deferred revenue declined to $8.54 million from $9.75 million, primarily as customer deposits were converted into revenue as obligations were fulfilled.
- The company recorded $139,999 of employee stock compensation related to restricted stock units, compared with $24,063 in the prior-year quarter.
Guidance, Outlook, Risks, and Unusual Items
Management did not provide formal revenue or earnings guidance. Bookings were $2.9 million in Q1 2024, and reported backlog was approximately $14 million, consisting of $5.4 million of capital, $6.4 million of service and warranty agreements, and $2.2 million of STEP contracts. Management expects most new capital bookings from the first quarter to convert to revenue during 2024, although delivery dates and contract terms may change at customer request. The filing also identifies $6.8 million of renewable STEP contracts over the next five years.
Management stated that existing capital resources should support operations and the current strategy for more than 12 months from the filing date. The company remains open to additional financing for product development, sales and marketing, and expansion, but financing may not be available on commercially reasonable terms.
Key operating risks include dependence on government customers and federal funding cycles, contract delays associated with continuing resolutions, customer concentration in accounts receivable, international sales volatility, execution of backlog, and the need to control increased operating expenses. Cash of $22.42 million was substantially above the FDIC standard insurance limit, with $22.42 million reported as uninsured.
Disclosure controls and procedures were determined to be ineffective as of March 31, 2024 because of material weaknesses previously identified in the 2023 Form 10-K. Management reported formal workflow documentation and increased ERP training as remediation efforts. No material off-balance-sheet arrangements or pending material litigation were reported.
Most Important Facts to Verify
- Whether federal funding delays and continuing resolutions continue to affect bookings, backlog conversion, and quarterly revenue.
- The timing and collectability of accounts receivable, particularly because operating cash flow was heavily supported by receivables collections.
- Progress in remediating the disclosed material weaknesses in internal control over financial reporting.
- Whether the $14 million reported backlog converts to revenue as expected and how much represents recurring STEP and warranty revenue.
- The cost, timing, and expected return of the company’s elevated capital expenditures.
- The company’s ability to maintain margins while adding staff, increasing IT spending, and expanding sales coverage.
- Exposure to government customer concentration, uninsured cash balances, and the secured mortgage’s future balloon payment.